| Literature DB >> 25713670 |
Abstract
The purpose of this study was to compare the effects of sprint interval training (SIT) and continuous endurance training (CET) on selected anthropometric, aerobic, and anaerobic performance indices as well as the blood lipid profile, inflammatory and muscle damage markers in healthy young males. Fifteen recreationally active male volunteers (age: 21.7 ±2.2 years, body mass: 83.0 ±8.0 kg, body height: 1.82 ±0.05 m) were divided into two groups according to their initial VO2max levels. Training programs were conducted 3 times per week for 7 weeks. The SIT program consisted of 4-6 Wingate anaerobic sprints with a 4.5 min recovery, while CET consisted of 30-50 min cycling at 60% VO2max. Biochemical, anthropometric and fitness assessments were performed both pre and post-intervention. Significant improvements in VO2max, anaerobic power and capacity, and VO2 utilization during the submaximal workout and significant decreases in body fat and in waist circumference after the intervention occurred in both SIT and CET groups. Significantly greater gross efficiency was measured in the CET group. No differences in the lipid profile or serum levels of inflammatory, myocardial and skeletal muscle damage markers were observed after the training period. The study results agree with the effectiveness of a 30 s all-out training program with a reduced time commitment for anthropometric, aerobic and anaerobic adaptation and eliminate doubts about its safety as a model.Entities:
Keywords: VO2max; Wingate test; gross efficiency; inflammation; lipids; muscle damage
Year: 2014 PMID: 25713670 PMCID: PMC4327385 DOI: 10.2478/hukin-2014-0115
Source DB: PubMed Journal: J Hum Kinet ISSN: 1640-5544 Impact factor: 2.193
Influence of CET and SIT on anthropometric indices
| CET (n=7) | SIT (n=8) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||||
| Week No | M ± SD | Δ% | p | d | Week No | M ± SD | Δ% | p | d | |||
| mass (kg) | W0 | 79.3 ± 6.69 | −1.1 | 0.140 | −0.132 | W0 | 86.2 ± 8.00 | −0.6 | 0.530 | −0.065 | ||
| W7 | 78.4 ± 6.96 | W7 | 85.7 ± 7.42 | |||||||||
| BMI (kg·m −2) | W0 | 24.5 ± 1.90 | −1.2 | 0.137 | −0.154 | W0 | 25.5 ± 2.23 | −0.8 | 0.573 | −0.090 | ||
| W7 | 24.2 ± 2.00 | W7 | 25.3 ± 2.20 | |||||||||
| waist (cm) | W0 | 82.4 ± 3.94 | −3.9 | 0.001[ | −0.868 | W0 | 86.8 ± 7.88 | −3.3 | 0.023[ | −0.393 | ||
| W7 | 79.2 ± 3.41 | W7 | 83.9 ± 6.85 | |||||||||
| hip (cm) | W0 | 100 ± 4.86 | −4.0 | 0.002[ | −0.711 | W0 | 102 ± 4.11 | −0.1 | 0.479 | 0.239 | ||
| W7 | 96.0 ± 6.30 | W7 | 101 ± 4.24 | |||||||||
| W/H (%) | W0 | 0.82 ± 0.31 | 1,2 | 0.655 | 0.030 | W0 | 0.85 ± 0.48 | −2.4 | 0.033[ | −0.040 | ||
| W7 | 0.83 ± 0.36 | W7 | 0.83 ± 0.51 | |||||||||
| BF (%) | W0 | 15.8 ± 2.62 | −5.7 | 0.015[ | −0.343 | W0 | 16.5 ± 3.72 | −7.3 | 0.007[ | −0.348 | ||
| W7 | 14.9 ± 2.63 | W7 | 15.3 ± 3.15 | |||||||||
| SS (mm) | W0 | 114 ± 24.3 | −10.5 | 0.015[ | −0.470 | W0 | 124 ± 43.1 | −10.5 | 0.010[ | −0.327 | ||
| W7 | 102 ± 26.7 | W7 | 111 ± 36.0 | |||||||||
p≤0.05,
CET: continuous endurance training, SIT: sprint interval training, BMI: body mass index, W/H: waist-to-hip ratio, BF: body fat, SS: sum of 8 skinfolds, M: mean, SD: standard deviation, Δ%: percentage change in means, d: Cohen’s d (<0.2 trivial; 0.2 ≤ d <0.5 small; 0.5 ≤ d <0.8 moderate; d ≥ 0.8 large effect size), W: week
Influence of CET and SIT on indices of the aerobic power test
| CET (n=7) | SIT (n=8) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| Week No | M ± SD | Paired Weeks | Δ% | p | d | Week No | M ± SD | Paired Weeks | Δ% | p | d | |
| VO2 max (ml•min−1•kg−1) | W0 | 40.5 ± 6.0 | W3-W0 | 4.4 | 0.038[ | 0.327 | W0 | 40.2 ± 4.3 | W3-W0 | 3.0 | 0.099 | 0.292 |
| W3 | 42.3 ± 5.0 | W7-W3 | 4.1 | 0.018[ | 0.358 | W3 | 41.4 ± 3.9 | W7-W3 | 3.9 | 0.009[ | 0.410 | |
| W7 | 44.0 ± 4.8 | W7-W0 | 8.7 | 0.014[ | 0.654 | W7 | 43.0 ± 3.9 | W7-W0 | 7.0 | 0.022[ | 0.682 | |
p≤0.05,
CET: continuous endurance training, SIT: sprint interval training, VO2max: maximal oxygen consumption, M: mean, SD: standard deviation, Δ%: percentage change in means, d: Cohen’s d (< 0.2 trivial; 0.2 ≤ d < 0.5 small; 0.5 ≤ d < 0.8 moderate; d ≥ 0.8 large effect size), W: week
Influence of CET and SIT on indices of the Wingate all-out test
| CET (n=7) | SIT (n=8) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Week No | M ± SD | Δ% | p | d | Week No | M ± SD | Δ% | p | d | |
| PP (W·kg−1) | W0 | 11.4 ± 1.4 | 9.6 | 0.008[ | 0.935 | W0 | 12.3 ± 1.7 | 8.9 | 0.011[ | 0.686 |
| W7 | 12.5 ± 0.9 | W7 | 13.4 ± 1.5[ | |||||||
| AP (W·kg−1) | W0 | 8.10 ± 0.50 | 3.7 | 0.033[ | 0.663 | W0 | 8.28 ± 0.70 | 3.9 | <0.001[ | 0.457 |
| W7 | 8.40 ± 0.40 | W7 | 8.60 ± 0.70 | |||||||
| FI (%) | W0 | 44.0 ± 10.1 | 18.6 | 0.122 | 0.816 | W0 | 51.2 ± 6.0 | 6.4 | 0.091 | 0.602 |
| W7 | 52.2 ± 10.0 | W7 | 54.5 ± 4.9 | |||||||
| tPP (s) | W0 | 1.94 ± 0.73 | −34.5 | 0.074 | −1.195 | W0 | 1.39 ± 0.37 | −12.3 | 0.092 | −0.559 |
| W7 | 1.27 ± 0.31 | W7 | 1.22 ± 0.22 | |||||||
| PD (%) | W0 | 57.0 ± 8.9 | 9.8 | 0.086 | 0.636 | W0 | 64.2 ± 6.8 | 0.8 | 0.811 | 0.083 |
| W7 | 62.6 ± 8.7 | W7 | 64.7 ± 5.1 | |||||||
p≤0.05,
p=0.040,
p=0.004 (statistically significantly higher compared with data of CET), CET: continuous endurance training, SIT: sprint interval training, PP: peak power, AP: average power, FI: fatigue index, tPP: time to peak power, PD: power drop, M: mean, SD: standard deviation, Δ%: percentage change in means, d: Cohen’s d (<0.2 trivial; 0.2 ≤ d < 0.5 small; 0.5 ≤ d < 0.8 moderate; d ≥ 0.8 large effect size), W: week
Influence of CET and SIT on indices of gross efficiency
| CET (n=7) | SIT (n=8) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Week No | M ± SD | Δ% | p | d | Week No | M ± SD | Δ% | p | d | |
| W0 | 1.96 ± 0.34 | 12.8 | 0.011[ | 0.826 | W0 | 1.97 ± 0.24 | 18.3 | 0.001[ | 1.765 | |
| W7 | 2.21 ± 0.26 | W7 | 2.33 ± 0.16 | |||||||
| GE (%) | W0 | 16.3 ± 1.59 | 18.4 | 0.001[ | 1.558 | W0 | 17.3 ± 2.43 | 8.8 | 0.071 | 0.800 |
| W7 | 19.3 ± 2.21 | W7 | 18.8 ± 1.19 | |||||||
p≤0.05,
CET: continuous endurance training, SIT: sprint interval training, GE: gross efficiency, VO2: oxygen consumption, M: mean, SD: standard deviation, Δ%: percentage change in means, d: Cohen’s d (<0.2 trivial; 0.2 ≤ d < 0.5 small; 0.5 ≤ d ≤ 0.8 moderate; d > 0.8 large effect size), W: week
Influence of CET and SIT on indices of the lipid profile
| CET (n=7) | SIT (n=8) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Week No | M ± SD | Δ% | p | D | Week No | M ± SD | Δ% | p | d | |
| TC (mg/dl) | W0 | 164 ± 26.8 | 1.2 | 0.749 | 0.086 | W0 | 178 ± 31.4 | −1.1 | 0.817 | −0.057 |
| W7 | 166 ± 18.9 | W7 | 176 ± 38.8 | |||||||
| HDL (mg/dl) | W0 | 48.1 ± 5.60 | −1.5 | 0.747 | −0.125 | W0 | 51.0 ± 10.7 | 2.9 | 0.111 | 0.142 |
| W7 | 47.4 ± 5.60 | W7 | 52.5 ± 10.5 | |||||||
| LDL (mg/dl) | W0 | 98.6 ± 22.1 | 0.8 | 0.813 | 0.039 | W0 | 104 ± 27.9 | 6.7 | 0.345 | 0.247 |
| W7 | 99.4 ± 18.8 | W7 | 111 ± 29 | |||||||
| VLDL (mg/dl) | W0 | 17.1 ± 10.2 | 9.4 | 0.368 | 0.135 | W0 | 23.0 ± 7.50 | −6.1 | 0.562 | −0.166 |
| W7 | 18.7 ± 13.3 | W7 | 21.6 ± 9.30 | |||||||
| TG (mg/dl) | W0 | 86.0 ± 51.4 | 8.1 | 0.420 | 0.117 | W0 | 115 ± 38.1 | −6.1 | 0.543 | −0.166 |
| W7 | 93.0 ± 67.0 | W7 | 108 ± 45.9 | |||||||
CET: continuous endurance training, SIT: sprint interval training, TC: total cholesterol, HDL: high-density lipoprotein, LDL: low-density lipoprotein, VLDL: very low-density lipoprotein, TG: triglyceride, M: mean, SD: standard deviation, Δ%: percentage change in means, d: Cohen’s d (<0.2 trivial; 0.2 ≤ d < 0.5 small; 0.5 ≤ d < 0.8 moderate; d ≥ 0.8 large effect size), W: week
Influence of CET and SIT on indices of inflammatory effect, myocardial damage and skeletal muscle damage
| CET (n=7) | SIT (n=8) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Week No | M ± SD | Δ% | p | D | Week No | M ± SD | Δ% | p | d | |
| WBC (103/µL) | W0 | 7.92 ± 2.35 | −2.1 | 0.758 | −0.078 | W0 | 6.91 ± 1.53 | 9.7 | 0.321 | 0.506 |
| W7 | 7.75 ± 2.02 | W7 | 7.58 ± 1.08 | |||||||
| CRP (mg/L) | W0 | 4.39 ± 2.76 | −26.2 | 0.312 | −0.589 | W0 | 3.27 ± 0.24 | 9.8 | 0.475 | 0.388 |
| W7 | 3.24 ± 0.13 | W7 | 3.59 ± 1.14 | |||||||
| AST (U/L) | W0 | 15.9 ± 4.81 | 0.0 | 1.000 | 0.000 | W0 | 17.4 ± 4.37 | 12.9 | 0.227 | 0.489 |
| W7 | 15.9 ± 2.41 | W7 | 19.6 ± 4.78 | |||||||
| ALT (U/L) | W0 | 11.1 ± 2.79 | 15.4 | 0.373 | 0.652 | W0 | 16.4 ± 8.95 | 34.3 | 0.018* | 0.741 |
| W7 | 12.9 ± 2.48 | W7 | 22.0 ± 5.92[ | |||||||
| CK (U/L) | W0 | 132 ± 61.1 | 11.5 | 0.743 | 0.217 | W0 | 134 ± 40.3 | 31.1 | 0.447 | 0.378 |
| W7 | 147 ± 77.4 | W7 | 175 ± 150 | |||||||
| CK-MB (U/L) | W0 | 13.5 ± 5.17 | 12.9 | 0.557 | 0.327 | W0 | 12.8 ± 4.46 | 20.0 | 0.320 | 0.639 |
| W7 | 15.3 ± 5.53 | W7 | 15.4 ± 3.53 | |||||||
| cTnI (ng/mL) | W0 | 0.031 ± 0.079 | 16.1 | 0.078 | 0.062 | W0 | 0.000 ± 0.000 | 0.3 | 0.170 | 0.849 |
| W7 | 0.036 ± 0.081 | W7 | 0.003 ± 0.005 | |||||||
p=0.002 (statistically significantly higher compared with data of CET), CET: continuous endurance training, SIT: sprint interval training, WBC: white blood cell, CRP: C-reactive protein, AST: aspartate aminotransferase, ALT: alanine aminotransferase, CK: creatine kinase, CK-MB: creatine kinase-myocardial band, cTnI: cardiac troponin I, M: mean, SD: standard deviation, Δ%: percentage change in means, d: Cohen’s d (<0.2 trivial; 0.2 ≤ d < 0.5 small; 0.5 ≤ d ≤ 0.8 moderate; d > 0.8 large effect size), W: week
| CET: | 1 | 4 | 5 | 8 | 9 | 12 | 13 | |
| SIT: | 2 | 3 | 6 | 7 | 10 | 11 | 14 | 15 |